The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.
The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.
The Indian peptide drugs market is expected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%.
The Indian peptide drugs market is expected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%.
The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.
Indian Peptide and Anticoagulant Drugs Market is projected to reach at $883.0 Million, at a CAGR of 15.0% and $170.2 Million by 2022, at a CAGR of 4.9%
Increasing prevalence of chronic diseases and favorable government policies for the pharmaceutical sector are driving the growth of this market.